A literature review on the efficacy and safety of Botulinum Toxin: An injection in post-stroke spasticity

International Journal of Preventive Medicine

Volumn 4, Issue , 2013, Pages S147-S158

  Ghasemi, Majid ^a   Salari, Mehri ^a   Khorvash, Fariborz ^a   Shaygannejad, Vahid ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Botulinum toxin A; Spasticity; Stroke

Indexed keywords

BOTULINUM TOXIN A;

ACETYLCHOLINE RELEASE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMAN; MOTOR PERFORMANCE; MULTICENTER STUDY (TOPIC); NEUROTRANSMITTER RELEASE; OBSERVATIONAL STUDY; OPEN STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPASTICITY;

EID: 84975687999     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Sommerfeld DK, Gripenstedt U, Welmer AK. Spasticity after stroke an overview of prevalence, test instruments, and treatments. Am J Phys Med Rehabil 2012;91:814-20.
2. Nabavi SM, Jafari B, Jalali MS, Nedjat S, Ashrafi K, Salahesh A. Environmental air pollution and acute cerebrovascular complications: An ecologic study in Tehran, Iran. Int J Prev Med 2012;3:723-9.
3. Zare M, Saadatnia M. The effect of statin therapy in stroke outcome: A double blind clinical trial. Int J Prev Med 2012;3:68-72.
4. Borg J, Ward AB, Wissel J. Rationale and design of a multicentre, double-blind, prospective, randomized, European and Canadian study: Evaluating patient outcomes and costs of managing adults with post-stroke focal spasticity. J Rehabil Med 2011;43:15-22.
5. Sommerfeld DK, Eek EU, Svensson AK. Spasticity after stroke: Its occurrence and association with motor impairments and activity limitations. Stroke 2004;35:134-9.
6. Ward AB. A literature review of the pathophysiology and onset of post-stroke spasticity. Eur J Neurol 2012;19:21-7.
7. Gallichio JE. Pharmacologic management of spasticity following stroke. Phys Ther 2004;84:973-81.
8. Ozcakir S, Sivrioglu K. Botulinum toxin in poststroke spasticity. Clin Med Res 2007;5:132-8.
9. Dhaked RK, Singh MK, Singh P, Gupta P. Botulinum toxin: bioweapon and magic drug. Indian J Med Res 2010;132:489-503.
10. Dolly O. Synaptic transmission: Inhibition of neurotransmitter release by botulinum toxins. Headache 2003;43:S16-24.
11. Raciborska DA, Charlton MP. Retention of cleaved synaptosome-associated protein of 25 kDa (SNAP-25) in neuromuscular junctions: A new hypothesis to explain persistence of botulinum A poisoning. Can J Physiol Pharmacol 1999;77:679-88.
12. Keller JE, Neale EA, Oyler G, Adler M. Persistence of botulinum neurotoxin action in cultured spinal cord cells. FEBS Lett 1999;456:137-42.
13. De Paiva A, Meunier FA, Molgó J, Aoki KR, Dolly JO. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: Biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci U S A 1999;96:3200-5.
14. Dobkin BH, Landau WM, Sahrmann S, Thomas Thach W, Simpson DM, Gracies JM, et al. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review). Neurology 2009;73:736.
15. Pittock SJ, Moore AP, Hardiman O, Ehler E, Kovac M, Bojakowski J, et al. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke. Cerebrovasc Dis 2003;15:289-300.
16. Yelnik AP, Bonan IV. Poststroke hemiplegia: Lower limb benefit from botulinum toxin (review). Ann Readapt Med Phys 2003;46:281-5.
17. Foley N, Murie-Fernandez M, Speechley M, Salter K, Sequeira K, Teasell R. Does the treatment of spastic equinovarus deformity following stroke with botulinum toxin increase gait velocity? A systematic review and meta-analysis. Eur J Neurol 2010;17:1419-27.
18. Dunne JW, Gracies JM, Hayes M, Zeman B, Singer BJ. Multicentre Study Group. A prospective, multicentre, randomized, double-blind, placebo-controlled trial of onabotulinumtoxin A to treat plantarflexor/invertor overactivity after stroke. Clin Rehabil 2012;26:787-97.
19. McIntyre A, Lee T, Janzen S, Mays R, Mehta S, Teasell R. Systematic review of the effectiveness of pharmacological interventions in the treatment of spasticity of the hemiparetic lower extremity more than six months post stroke. Top Stroke Rehabil 2012;19:479-90.
20. Girlanda P, Quartarone A, Sinicropi S. Botulinum toxin in upper limb spasticity: Study of reciprocal inhibition between forearm muscles. Neuroreport 1997;8:3039-44.
21. Lagalla G, Danni M, Reiter F, Ceravolo MG, Provinciali L. Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb. Am J Phys Med Rehabil 2000;79:377-84.
22. Bakheit AM, Pittock S, Moore AP, Wurker M, Otto S, Erbguth F, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. Eur J Neurol 2001;8:559-6.
23. Brashear A, Gordon MF, Elovic E, Kassicieh VD, Marciniak C, Do M, et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med 2002;374:395-400.
24. van Kuijk AA, Geurts AC, Bevaart BJ, van Limbeek J. Treatment of upper extremity spasticity in stroke patients by focal neuronal or neuromuscular blockade: A systematic review of the literature. J Rehabil Med 2002;34:51-61.
25. Rousseaux M, Launay MJ, Kozlowski O. Poststroke hemiplegia: Interest of botulinum toxin injection at the upper limb. Ann Readapt Med Phys 2003;46:286-95.
26. Yelnik AP. Pharmacology and upper limb poststroke spasticity: A review International Society of Prosthetics and Orthotics. Ann Readapt Med Phys 2004;47:575-89.
27. Miscio G, Del Conte C, Pianca D. Botulinum toxin in post-stroke patients: Stiffness modifications and clinical implications. J Neurol 2004;251:189-96.
28. Cardoso E, Rodrigues B, Lucena R, Oliveira IR, Pedreira G, Melo A. Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: A meta-analysis. Arq Neuropsiquiatr 2005;63:30-3.
29. Slawek J, Bogucki A, Reclawowicz D. Botulinum toxin type A for upper limb spasticity following stroke: An open-label study with individualised, flexible injection regimens. Neurol Sci 2005;26:32-9.
30. Jahangir AW, Tan HJ, Norlinah MI. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke. Med J Malaysia 2007;62:319-22.
31. Bhakta BB, O'Connor RJ, Cozens JA. Associated reactions after stroke: A randomized controlled trial of the effect of botulinum toxin type A. J Rehabil Med 2008;40:36-41.
32. Trompetto C, Bove M, Avanzino L. Intrafusal effects of botulinum toxin in post-stroke upper limb spasticity. Eur J Neurol 2008;15:367-70.
33. McCrory P, Turner-Stokes L, Baguley IJ, De Graaff S, Katrak P, Sandanam J, et al. Botulinum toxin A for treatment of upper limb spasticity following stroke: A multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes. J Rehabil Med 2009;41:536-44.
34. Ashford S, Turner-Stokes L. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: A preliminary analysis of goals and outcomes. Disabil Rehabil 2009;31:220-6.
35. Senkárová Z, Hlustík P, Otruba P, Herzig R, Kanovský P. Modulation of cortical activity in patients suffering from upper arm spasticity following stroke and treated with botulinum toxin A: An fMRI study. J Neuroimaging 2010;20:9-15.
36. Turner-Stokes L, Baguley IJ, De Graaff S, Katrak P, Davies L, McCrory P, et al. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: A secondary analysis from a double-blind placebo-controlled randomized clinical trial. J Rehabil Med 2010;42:81-9.
37. Kaňovský P, Slawek J, Denes Z, Platz T, Comes G, Grafe S, et al. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity. J Rehabil Med 2011;43:486-92.
38. Kaji R, Osako Y, Suyama K, Maeda T, Uechi Y, Iwasaki M, et al. Botulinum toxin type A in post-stroke upper limb spasticity. Curr Med Res Opin 2010;26:1983-92.
39. Cousins E, Ward A, Roffe C. Does low-dose botulinum toxin help the recovery of arm function when given early after stroke? A phase II randomized controlled pilot study to estimate effect size. Clin Rehabil 2010;24:501-13.
40. Baguley IJ, Nott MT, Turner-Stokes L, De Graaff S, Katrak P, McCrory P, et al. Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity. J Rehabil Med 2011;43:1032-7.
41. Tomášová Z, Hluštík P, Král M, Otruba P, Herzig R, Krobot A, et al. Cortical activation changes in patients suffering from post-stroke arm spasticity and treated with botulinum toxin A. J Neuroimaging 2011;20:1-8.
42. Rosales RL, Kanovsky P, Fernandez HH. What's the "catch" in upper-limb post-stroke spasticity: Expanding the role of botulinum toxin applications. Parkinsonism Relat Disord 2011;17 (Suppl 1):S3-10.
43. Yablon SA, Brin MF, VanDenburgh AM, Zhou J, Garabedian-Ruffalo SM, Abu-Shakra S, et al. Dose response with onabotulinumtoxin A for post-stroke spasticity: A pooled data analysis. Mov Disord 2011;26:209-15.
44. Veverka T, Hluštík P, Tomášová Z, Hok P, Otruba P, Král M, et al. BoNT-A related changes of cortical activity in patients suffering from severe hand paralysis with arm spasticity following ischemic stroke. J Neurol Sci 2012;319:89-9.
45. Rosales RL, Kong KH, Goh KJ, Kumthornthip W, Mok VC, Delgado-De Los Santos MM, et al. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: A randomized controlled trial. Neurorehabil Neural Repair 2012;26:812-21.
46. Viriyavejakul A, Vachalathiti R, Poungvarin N. Botulinum treatment for post-stroke spasticity: Low dose regime. J Med Assoc Thai 1998;81:413-22.
47. Wissel J, Müller J, Heinen F, Mall V, Sojer M, Ebersbach G, et al. Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group. Wien Klin Wochenschr 1999;111:837-42.
48. Fève A. Spasticity and botulinum toxin in 2003. An update. Neurochirurgie 2003;49:265-70.
49. Ward A, Roberts G, Warner J. Cost-effectiveness of botulinum toxin type A in the treatment of post-stroke spasticity. J Rehabil Med 2005;37:252-7.
50. Cardoso E, Pedreira G, Prazeres A, Ribeiro N, Melo A. Does botulinum toxin improve the function of the patient with spasticity after stroke? Arq Neuropsiquiatr 2007;65:592-5.
51. Rosales RL, Chua-Yap AS. Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity. J Neural Transm 2008;115:617-23.
52. Elia AE, Filippini G, Calandrella D, Albanese A. Botulinum neurotoxins for post-stroke spasticity in adults: A systematic review. Mov Disord 2009;24:801-81.
53. Teasell R, Foley N, Pereira S, Sequeira K, Miller T. Evidence to practice: Botulinum toxin in the treatment of spasticity post stroke. Top Stroke Rehabil 2012;19:115-21.